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106A CLINICAL RESEARCH 
SECOND ACUTE LEUKEMIA IN CHILDHOOD. J.D. Reeves, F .L. Meyskens( S.G. Barrett,* and M. MacKenzie,* Department of Pediatrics, Dav d 
Grant Medical Center, Travis Air Force Base, California, Departments 
of Internal Medicine, University of Arizona Health Sciences Center, 
Tucson, and University of California, Davis, and the Cancer Research 
Institute, University of California, San Francisco. 
A child with acute lymphocyt1c leukemia (ALL) developed acute 
myelocytic leukemia (AML) after two years of continuous complete 
remission achieved with ALL type chemotherapy and cranial radiation. 
Comparison of blast morphology and histochemical staining features 
b�fo�e and after this therapy indicated that the second leukemia was 
d1st1nct from the first leukemia. There were nonnal numbers of T 
cells and B cells in bone marrow, few leukemic cells with surface 
complement receptors, low levels of terminal deoxynucleotidyl trans­
ferase activity, and nonnal ser\BII muramidase activity at diagnosis of 
the second leukemia. Sixty one per cent of marrow karyotype meta­
phase plates had an elongated group D chromosome and at least one 
missing group D chromosome suggesting a possible translocation. A 
bone marrow remission was induced after four cycles of AML type 
chemotherapy but the patient expired eleven months later with pro­
gressive disease. Histochemical stains, cell surface markers, 
enzyme studies, and cytogenetic analyses make it possible to deter­
mine the frequency of second acute 1 eukemi a as a second ma 1 i gnancy 
in children. 
